Vonoprazan (fumarate)

Vonoprazan is a selective, reversible, and potassium-competitive proton pump inhibitor that inhibits gastric H+/K+ ATPase (IC50 = 17 nM) but does not inhibit porcine Na+/K+ ATPase activity when used at a concentration of 10 µM. It maintains its inhibitory effect in both weakly acidic (pH 6.5) and neutral (pH 7.5) conditions with IC50 values of 19 and 28 nM, respectively. In vivo, vonoprazan (1, 2, and 4 mg/kg) inhibits histamine-stimulated acid secretion in a dose-dependent manner in rats, with complete inhibition when administered at a dose of 4 mg/kg. It also inhibits acid secretion for more than 48 hours in dogs when administered at doses ranging from 0.1 to 1 mg/kg.Formal Name: 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanamine, 2-butenedioate. CAS Number: 881681-01-2. Synonyms: TAK-438. Molecular Formula: C17H16FN3O2S . C4H4O4. Formula Weight: 461.5. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMSO: soluble. SMILES: FC(C=CC=C1)=C1C2=CC(CNC)=CN2S(C3=CC=CN=C3)(=O)=O.OC(/C=C/C(O)=O)=O. InChi Code: InChI=1S/C17H16FN3O2S.C4H4O4/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14,5-3(6)1-2-4(7)8/h2-9,11-12,19H,10H2,1H3,1-2H,(H,5,6)(H,7,8)/b,2-1+. InChi Key: ROGSHYHKHPCCJW-WLHGVMLRSA-N.